Amicus Therapeutics Inc. buy Wells Fargo & Company
Start price
20.02.25
/
50%
€8.70
Target price
20.02.26
€16.27
Performance (%)
36.78%
End price
21.02.26
€11.90
Summary
This prediction ended on 21.02.26 with a price of €11.90. The BUY prediction by Wells_Fargo___Compan for Amicus Therapeutics Inc. saw massive gains of 36.78%. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amicus Therapeutics Inc. | 0.833% | 0.833% | 41.520% |
| iShares Core DAX® | 1,43 % | 1,58 % | 13,25 % |
| iShares Nasdaq 100 | 1,89 % | -2,28 % | 2,99 % |
| iShares Nikkei 225® | -1,62 % | 7,95 % | 27,69 % |
| iShares S&P 500 | 1,92 % | -0,28 % | 2,99 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target lowered by analysts at Wells Fargo & Company from $18.00 to $17.00. They now have an "overweight" rating on the stock.
Ratings data for FOLD provided by MarketBeat
In the thread Trading Amicus Therapeutics Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Wells_Fargo___Compan for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.90
30.05.24
30.05.24
€16.62
30.05.25
30.05.25
-39.89%
31.05.25
31.05.25
